Experts Urge Action Amid Rising Antibiotic Resistance Crisis

Pharmaceutical companies withdraw from antibiotic production as resistance threats grow, prompting calls for government incentives.

Antibiotic resistance leads to 35,000 deaths annually in the EU, with the effectiveness of current medications increasingly compromised.
Since 2017, only twelve new antibiotics have been approved, with most facing existing resistance issues.
Experts warn of a regression to pre-penicillin times if new, resistance-breaking antibiotics are not developed.
Pharmaceutical firms are abandoning antibiotic production due to unprofitable returns, exacerbating the crisis.
Proposed EU measures suggest extending exclusive marketing rights for other drugs to fund antibiotic research.